Trials / Completed
CompletedNCT03348397
Contegra Versus Pulmonary Homograft for Right Ventricular Outflow Tract Reconstruction in Newborns
Contegra Versus Pulmonary Homograft for Right Ventricular Outflow Tract Reconstruction in Newborns : Fifteen Years' Experience
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 53 (actual)
- Sponsor
- Queen Fabiola Children's University Hospital · Academic / Other
- Sex
- All
- Age
- 30 Days
- Healthy volunteers
- Not accepted
Summary
Pulmonary homografts are standard substitutes for right ventricular outflow tract reconstruction in congenital heart surgery. Unfortunately shortage and conduit failure secondary to early calcifications and shrinking are observed particularly for small sized conduits in younger patients. In neonates, Contegra® 12mm could be a valuable alternative, but conflicting evidence exists. This retrospective study compared the outcome of these two conduits in a newborn population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | right ventricular outflow tract reconstruction with contegra | Contegra pulmonary valved conduit is an animal jugular vein that contains a valve with three leaflets that are similar to a human heart valve. |
| PROCEDURE | right ventricular outflow tract reconstruction with pulmonary homograft | cryopreserved pulmonary homografts |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2017-06-01
- Completion
- 2017-10-30
- First posted
- 2017-11-20
- Last updated
- 2017-11-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03348397. Inclusion in this directory is not an endorsement.